Capital Advisors Inc. OK Sells 7,665 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Advisors Inc. OK decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 122,086 shares of the medical equipment provider's stock after selling 7,665 shares during the quarter. Intuitive Surgical accounts for about 1.2% of Capital Advisors Inc. OK's investment portfolio, making the stock its 20th biggest position. Capital Advisors Inc. OK's holdings in Intuitive Surgical were worth $60,466,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new position in Intuitive Surgical in the fourth quarter valued at about $25,000. Chilton Capital Management LLC boosted its position in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares in the last quarter. Parvin Asset Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. Global Financial Private Client LLC boosted its position in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares in the last quarter. Finally, Elite Financial Inc. acquired a new position in Intuitive Surgical in the first quarter valued at about $26,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded up $0.83 during trading hours on Wednesday, hitting $528.13. The stock had a trading volume of 1,380,875 shares, compared to its average volume of 1,674,064. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The company has a market cap of $189.29 billion, a price-to-earnings ratio of 77.44, a P/E/G ratio of 5.59 and a beta of 1.64. The business's 50 day moving average is $538.02 and its 200-day moving average is $536.87.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director directly owned 6,371 shares of the company's stock, valued at $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock worth $2,611,577 over the last three months. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent analyst reports. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Royal Bank Of Canada reduced their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $592.59.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.